Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -35.96% | -36.29% | -37.62% | -39.47% | -43.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -35.96% | -36.29% | -37.62% | -39.47% | -43.80% |
| Cost of Revenue | -29.93% | -32.98% | -37.39% | -41.14% | -46.71% |
| Gross Profit | -38.11% | -37.47% | -37.70% | -38.85% | -42.69% |
| SG&A Expenses | -32.85% | -37.83% | -36.44% | -31.58% | -34.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.87% | -36.28% | -36.48% | -34.24% | -37.92% |
| Operating Income | -192.40% | -37.29% | -62.07% | -92.36% | -87.83% |
| Income Before Tax | -248.84% | -83.61% | -83.23% | -108.35% | -97.06% |
| Income Tax Expenses | 668.51% | -64.50% | -67.13% | -101.43% | -94.23% |
| Earnings from Continuing Operations | -992.54% | -96.61% | -87.60% | -110.32% | -97.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -992.54% | -96.61% | -87.60% | -110.32% | -97.90% |
| EBIT | -192.40% | -37.29% | -62.07% | -92.36% | -87.83% |
| EBITDA | -99.89% | -12.47% | -43.62% | -79.94% | -79.87% |
| EPS Basic | -979.45% | -96.65% | -87.70% | -110.28% | -97.89% |
| Normalized Basic EPS | -134.37% | 17.22% | -49.98% | -94.02% | -87.40% |
| EPS Diluted | -1,049.97% | -98.57% | -88.07% | -110.50% | -98.02% |
| Normalized Diluted EPS | -134.72% | 17.53% | -49.94% | -94.07% | -87.44% |
| Average Basic Shares Outstanding | 0.46% | 0.44% | 0.42% | 0.41% | 0.42% |
| Average Diluted Shares Outstanding | 0.32% | 0.41% | 0.45% | 0.22% | 0.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.03% | -0.69% | -0.96% | -1.04% | -0.53% |